Literature DB >> 25837597

The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study.

Chia-Jung Kuo1, Kuang-Hui Yu, Lai-Chu See, Cheng-Tang Chiu, Ming-Yao Su, Chen-Ming Hsu, Chang-Fu Kuo, Meng-Jiun Chiou, Jia-Rou Liu, Hung-Wei Wang.   

Abstract

BACKGROUND AND AIM: The purpose of this study was to estimate the sex- and age-specific incidence rates of inflammatory bowel diseases (IBD) in Taiwan. Site-specific cancer occurred in patients with IBD would be reported, too.
METHODS: A retrospective study by analyzing the data from the National Health Insurance Research Database of Taiwan.
RESULTS: Between 2000 and 2010, the overall incidence rate of Crohn's disease (CD) and ulcerative colitis (UC) was 0.208 and 0.838 per 100,000 person-years. For male, the incidence rate of CD was 0.195 (95 % CI 0.113-0.276) per 100,000 persons in 2000 and increased to 0.318 (95 % CI 0.216-0.421) per 100,000 persons in 2010. For female, the incidence rate of CD was 0.092 (95 % CI 0.035-0.149) per 100,000 persons in 2000 and increased to 0.210 (95 % CI 0.128-0.293) per 100,000 persons in 2010. For male, the incidence rate of UC was 0.690 (95 % CI 0.537-0.843) per 100,000 persons in 2000 and increased to 1.351 (95 % CI, 1.140-1.562) per 100,000 persons in 2010. For female, the incidence rate of UC was 0.386 (95 % CI 0.269-0.503) per 100,000 persons in 2000 and increased to 0.858 (95 % CI 0.691-1.024) per 100,000 persons in 2010. Among the CD patients, 0.19 % had colorectal cancers (1/519). Among the UC patients, 0.24 % had colorectal cancers (5/2098).
CONCLUSIONS: This nationwide population-based longitudinal epidemiological study of IBD in Taiwan provides data for future global comparisons.

Entities:  

Mesh:

Year:  2015        PMID: 25837597     DOI: 10.1007/s10620-015-3630-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

Review 1.  Crohn's disease in Japan: diagnostic criteria and epidemiology.

Authors:  T Yao; T Matsui; N Hiwatashi
Journal:  Dis Colon Rectum       Date:  2000-10       Impact factor: 4.585

2.  Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.

Authors:  Tine Jess; Christine Rungoe; Laurent Peyrin-Biroulet
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

Review 3.  New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations.

Authors:  Michael Economou; Georgios Pappas
Journal:  Inflamm Bowel Dis       Date:  2008-05       Impact factor: 5.325

Review 4.  The Asia-Pacific consensus on ulcerative colitis.

Authors:  Choon Jin Ooi; Kwong Ming Fock; Govind K Makharia; Khean Lee Goh; Khoon Lin Ling; Ida Hilmi; Wee Chian Lim; Thia Kelvin; Peter R Gibson; Richard B Gearry; Qin Ouyang; Jose Sollano; Sathaporn Manatsathit; Rungsun Rerknimitr; Shu-Chen Wei; Wai Keung Leung; H Janaka de Silva; Rupert Wl Leong
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

5.  Epidemiology and natural history of inflammatory bowel diseases.

Authors:  Jacques Cosnes; Corinne Gower-Rousseau; Philippe Seksik; Antoine Cortot
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

6.  Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.

Authors:  C-F Kuo; L-C See; K-H Yu; I-J Chou; W-Y Tseng; H-C Chang; Y-M Shen; S-F Luo
Journal:  Scand J Rheumatol       Date:  2011-03-09       Impact factor: 3.641

7.  Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.

Authors:  Tine Jess; Jacob Simonsen; Kristian Tore Jørgensen; Bo Vestergaard Pedersen; Nete Munk Nielsen; Morten Frisch
Journal:  Gastroenterology       Date:  2012-04-19       Impact factor: 22.682

8.  Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis.

Authors:  Matthew D Rutter; Brian P Saunders; Kay H Wilkinson; Steve Rumbles; Gillian Schofield; Michael A Kamm; Christopher B Williams; Ashley B Price; Ian C Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 9.  An update on the epidemiology of inflammatory bowel disease in Asia.

Authors:  Kelvin T Thia; Edward V Loftus; William J Sandborn; Suk-Kyun Yang
Journal:  Am J Gastroenterol       Date:  2008-12       Impact factor: 10.864

10.  Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study.

Authors:  Suk-Kyun Yang; Sungcheol Yun; Jin-Ho Kim; Joon Yong Park; Hak Yang Kim; Young-Ho Kim; Dong Kyung Chang; Joo Sung Kim; In Sung Song; Jong Beom Park; Eui-Ryun Park; Kyung Jo Kim; Gyoo Moon; Soo Hyun Yang
Journal:  Inflamm Bowel Dis       Date:  2008-04       Impact factor: 5.325

View more
  7 in total

Review 1.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

Review 2.  Changing epidemiological trends of inflammatory bowel disease in Asia.

Authors:  Wee Khoon Ng; Sunny H Wong; Siew C Ng
Journal:  Intest Res       Date:  2016-04-27

3.  A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease.

Authors:  Guanglin Cui; Aping Yuan
Journal:  Front Med (Lausanne)       Date:  2018-06-19

Review 4.  Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Authors:  Shu-Chen Wei; Ting-An Chang; Te-Hsin Chao; Jinn-Shiun Chen; Jen-Wei Chou; Yenn-Hwei Chou; Chiao-Hsiung Chuang; Wen-Hung Hsu; Tien-Yu Huang; Tzu-Chi Hsu; Chun-Chi Lin; Hung-Hsin Lin; Jen-Kou Lin; Wei-Chen Lin; Yen-Hsuan Ni; Ming-Jium Shieh; I-Lun Shih; Chia-Tung Shun; Yuk-Ming Tsang; Cheng-Yi Wang; Horng-Yuan Wang; Meng-Tzu Weng; Deng-Chyang Wu; Wen-Chieh Wu; Hsu-Heng Yen; Jau-Min Wong
Journal:  Intest Res       Date:  2017-06-12

Review 5.  Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Authors:  Shu-Chen Wei; Ting-An Chang; Te-Hsin Chao; Jinn-Shiun Chen; Jen-Wei Chou; Yenn-Hwei Chou; Chiao-Hsiung Chuang; Wen-Hung Hsu; Tien-Yu Huang; Tzu-Chi Hsu; Chun-Chi Lin; Hung-Hsin Lin; Jen-Kou Lin; Wei-Chen Lin; Yen-Hsuan Ni; Ming-Jium Shieh; I-Lun Shih; Chia-Tung Shun; Yuk-Ming Tsang; Cheng-Yi Wang; Horng-Yuan Wang; Meng-Tzu Weng; Deng-Chyang Wu; Wen-Chieh Wu; Hsu-Heng Yen; Jau-Min Wong
Journal:  Intest Res       Date:  2017-06-12

Review 6.  Current global trends in the incidence of pediatric-onset inflammatory bowel disease.

Authors:  Josef Sýkora; Renáta Pomahačová; Marcela Kreslová; Dominika Cvalínová; Přemysl Štych; Jan Schwarz
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

7.  Mesalazine-related lung disease in a patient with ulcerative colitis: A case report.

Authors:  Po-Han Huang; Chia-Jung Kuo; Chang-Wei Lin; Yu-Ming Cheng; Han-Chung Hu; Chun-Yen Lin; Ming-Yao Su; Cheng-Tang Chiu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.